Phase 3 trial with the RTS,S/AS01 malaria vaccine shows protection against clinical and severe malaria in infants and children in Africa.

Evid Based Med

Faculty of Infectious and Tropical Diseases, Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.

Published: February 2015

Download full-text PDF	Source
http://dx.doi.org/10.1136/ebmed-2014-110089	DOI Listing

Publication Analysis

phase trial

trial rtss/as01

rtss/as01 malaria

malaria vaccine

vaccine protection

protection clinical

clinical severe

severe malaria

malaria infants

infants children

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!